Osteoporosis

Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 per cent continuing to make osteoporosis a hot topic in medicine. It recognizes the critical importance of the Wnt signaling pathway for bone health. It incorporates new chapters on osteocytes, phosphatonins, mouse genetics, and CNS and bone. It examines essential updates on estrogen prevention and treatment and the recent results from the WHI. It discusses the controversial topics of screening and clinical trial design for drug registration. It includes essential updates on therapeutic uses of calcium, vitamin D, SERMS, bisphosphonates, and parathyroid hormone. It offers critical reviews of reproductive and hormonal risk factors, ethnicity, nutrition, therapeutics, management, and economics.